Zebra Imaging Analytics EngineZebra Medical Vision
|
||||||
Related Products
|
||||||
About
CorneaDX by VistaMed AI Vision uses deep learning for comprehensive corneal disease detection - built beyond the 5-6 disease limit of existing solutions. Detects keratoconus, keratitis, dystrophies, and rare corneal conditions.
|
About
Zebra’s Imaging Analytics Engine receives imaging scans from various modalities and automatically analyzes them for a number of different clinical findings, in a timely manner and full synergy with radiology workflow. Providers use Zebra-Med to alert them of patients at high risk of cardiovascular, lung, bone and other diseases. This facilitates preventative care programs, proper risk adjustments and allocation, as well as conformance with quality standards such as MACRA. With Zebra-Med – focus can be provided to the right patients, at the right time – saving overall costs while improving care.
|
|||||
Platforms Supported
Windows
Mac
Linux
Cloud
On-Premises
iPhone
iPad
Android
Chromebook
|
Platforms Supported
Windows
Mac
Linux
Cloud
On-Premises
iPhone
iPad
Android
Chromebook
|
|||||
Audience
Keratoconus & corneal thinning disorders
|
Audience
Doctors
|
|||||
Support
Phone Support
24/7 Live Support
Online
|
Support
Phone Support
24/7 Live Support
Online
|
|||||
API
Offers API
|
API
Offers API
|
|||||
Screenshots and VideosNo images available
|
Screenshots and VideosNo images available
|
|||||
Pricing
No information available.
Free Version
Free Trial
|
Pricing
No information available.
Free Version
Free Trial
|
|||||
Reviews/
|
Reviews/
|
|||||
Training
Documentation
Webinars
Live Online
In Person
|
Training
Documentation
Webinars
Live Online
In Person
|
|||||
Company InformationCorneaDx
Founded: 2026
India
corneadx.org
|
Company InformationZebra Medical Vision
Founded: 2014
Israel
www.zebra-med.com/solutions
|
|||||
AlternativesNo Alternatives
|
Alternatives |
|||||
|
|
||||||
|
|
||||||
|
|
||||||
Categories |
Categories |
|||||
Integrations
No info available.
|
Integrations
No info available.
|
|||||
|
|
|